T Feichtenschlager

Inflammatory Bowel Disease Is a Risk Factor for Recurrent Venous Thromboembolism

Gottfried Novacek, Ansgar Weltermann, Anna Sobala et al. · Gastroenterology · 2010 · 263 citations · Full text

Inflammation, Thrombosis, Epidemiology +10

Clinical presentation of venous thromboembolism in inflammatory bowel disease

Pavol Papay, Wolfgang Miehsler, Herbert Tilg et al. · Journal of Crohn s and Colitis · 2012 · 109 citations · Full text

Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia

Christoph Gasché, Thomas Waldhoer, T Feichtenschlager et al. · The American Journal of Gastroenterology · 2001 · 96 citations

The efficacy and safety of either infliximab or adalimumab in 362 patients with anti‐<scp>TNF</scp>‐α naïve Crohn's disease

Neeraj Narula, Stephanie Kainz, Wolfgang Petritsch et al. · Alimentary Pharmacology & Therapeutics · 2016 · 67 citations · Full text

A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease

Alexander Teml, Matthias Schwab, Daan W. Hommes et al. · Wiener klinische Wochenschrift · 2007 · 44 citations

Hepatology, 6-Thioguanine-related Hepatotoxicity, Pharmacology +8